MedTrace Logo

Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans

NCT03584919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 509

Last updated 2018-07-12

No results posted yet for this study

Summary

A European, prospective clinical trial in which doxycycline and cefuroxime axetil were compared in the treatment of adult patients with erythema migrans included a control group to address this question. Evaluations of patients were conducted at baseline, 14 days and 2, 6, and 12 months after enrollment. Control subjects were evaluated at baseline and at 6 and 12 months. Subjective complaints that newly developed or intensified since the onset of erythema migrans or since the date of enrollment for controls were referred to as "new or increased symptoms"(NOIS).

Conditions

  • Erythema Chronicum Migrans

Interventions

DRUG

doxycycline

patients received oral doxycycline 100 milgrams bid for 15 days

DRUG

Cefuroxime Axetil 500Mg Tab

patients received cefuroxime axetil 500 milgrams bid for 15 days

OTHER

control subjects

no intervention

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-01
Primary Completion
2007-09-30
Completion
2007-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03584919 on ClinicalTrials.gov